ASCO 2023 | What makes cancer treatment worth it for patients

Sachia Stonefeld Powell, The Powell-Drescher Ovarian Cancer Research Foundation, Seattle, WA, provides a patient perspective on the use of antibody-drug conjugates (ADCs) for the management of gynecological cancer, which often differ greatly between patients and can be overlooked by practitioners. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.